Growth Metrics

Mannkind (MNKD) Assets Average (2011 - 2026)

Mannkind (MNKD) reported Assets Average of $768.3 million for Q1 2026, up 91.12% year-over-year from $402.0 million in Q1 2025, and up 19.41% on a QoQ basis from $643.4 million in Q4 2025.

Mannkind (MNKD) has 16 years of Assets Average data on file, last reported at $768.3 million in Q1 2026.

  • Quarterly Assets Average rose 91.12% year-over-year to $768.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $768.3 million (up 91.12% YoY) and the FY2025 annual result came in at $593.0 million, up 36.48% from the prior year.
  • Assets Average advanced to $768.3 million in Q1 2026 per MNKD's latest filing, from $643.4 million in the prior quarter.
  • Across five years, Assets Average topped out at $768.3 million in Q1 2026 and bottomed at $289.8 million in Q3 2022.
  • The 5-year median for Assets Average is $402.0 million (2025), against an average of $412.6 million.
  • The widest annual swing landed in 2025, when Assets Average dropped 15.91%; it then surged 91.12% in 2026.
  • Tracing MNKD's Assets Average over 5 years: stood at $294.6 million in 2022, then jumped by 35.04% to $397.8 million in 2023, then rose by 7.86% to $429.0 million in 2024, then soared by 49.97% to $643.4 million in 2025, then advanced by 19.41% to $768.3 million in 2026.
  • Per Business Quant, the three latest MNKD Assets Average figures stand at $768.3 million (Q1 2026), $643.4 million (Q4 2025), and $453.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 13.04 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 33.42 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.72 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 331.70 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 40.89 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 26.06 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 26.03 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 40.71 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 5.05 Bn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 768.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 768.29 Mn
Dec 31, 2025 643.41 Mn
Sep 30, 2025 453.17 Mn
Jun 30, 2025 410.92 Mn
Mar 31, 2025 401.99 Mn
Dec 31, 2024 429.02 Mn
Sep 30, 2024 454.02 Mn
Jun 30, 2024 462.36 Mn
Mar 31, 2024 478.04 Mn
Dec 31, 2023 397.76 Mn
Sep 30, 2023 316.88 Mn
Jun 30, 2023 305.78 Mn
Mar 31, 2023 296.71 Mn
Dec 31, 2022 294.56 Mn
Sep 30, 2022 289.82 Mn
Jun 30, 2022 297.06 Mn
Mar 31, 2022 314.74 Mn
Dec 31, 2021 279.68 Mn
Sep 30, 2021 245.50 Mn
Jun 30, 2021 286.09 Mn
Mar 31, 2021 214.00 Mn
Dec 31, 2020 102.14 Mn
Sep 30, 2020 99.23 Mn
Jun 30, 2020 91.50 Mn
Mar 31, 2020 86.97 Mn
Dec 31, 2019 94.43 Mn
Sep 30, 2019 88.47 Mn
Jun 30, 2019 91.38 Mn
Mar 31, 2019 104.33 Mn
Dec 31, 2018 76.53 Mn
Sep 30, 2018 53.76 Mn
Jun 30, 2018 62.02 Mn
Mar 31, 2018 73.23 Mn
Dec 31, 2017 70.53 Mn
Sep 30, 2017 67.93 Mn
Jun 30, 2017 82.28 Mn
Mar 31, 2017 96.12 Mn
Dec 31, 2016 101.60 Mn
Sep 30, 2016 117.78 Mn
Jun 30, 2016 116.35 Mn
Mar 31, 2016 109.84 Mn
Dec 31, 2015 202.21 Mn
Sep 30, 2015 315.28 Mn
Jun 30, 2015 356.29 Mn
Mar 31, 2015 377.23 Mn
Dec 31, 2014 390.63 Mn
Sep 30, 2014 311.56 Mn
Jun 30, 2014 230.43 Mn
Mar 31, 2014 241.60 Mn
Dec 31, 2013 273.13 Mn
Sep 30, 2013 250.02 Mn
Jun 30, 2013 213.81 Mn
Mar 31, 2013 233.26 Mn
Dec 31, 2012 230.82 Mn
Sep 30, 2012 225.36 Mn
Jun 30, 2012 245.91 Mn
Mar 31, 2012 225.49 Mn
Dec 31, 2011 211.78 Mn
Sep 30, 2011 226.19 Mn